S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 1, 2003, Pages

  Wirds, J W ^a   Leusink, J A ^a   Duyn, A E J ^a   Geraerts, S D ^a   Preijer, E ^b   Van Diemen Steenvoorde, J A A M ^a   Schagen van Leeuwen, J H ^a   Haas, F J L M ^a   Gerritsen, W B M ^a   De Boer, A ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

ARTICLE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM DISEASE; CESAREAN SECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DISEASE ASSOCIATION; DISEASE MARKER; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN HYPOXIA; PRIORITY JOURNAL; PROTEIN CONTENT; UMBILICAL CORD BLOOD; VAGINAL DELIVERY;

EID: 0037235458     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.88.1.f67     Document Type: Article

References (15)

1. Vaagenes P, Kjekshus J, Sivertsen E, et al. Temporal pattern of enzyme changes in cerebrospinal fluid in patients with neurologic complications after open heart surgery. Crit Care Med 1987;15:726-31.
2. Rossi R, Ekroth R, Thompson R. No flow or low flow? A study of the ischemic marker creatinine kinase BB after deep hypothermic procedures. J Thorac Cardiovasc Surg 1989;98:193-9.
3. Kumpel B, Wood S, Anthony P, et al. Umbilical cord serum creatinine kinase BB in the diagnosis of brain damage in the newborn: problems in interpretation. Arch Dis Child 1983;58:382-3.
4. Ghandour M, Langley O, Keller A. A comparative immunohistological study of cerebellar enolases. Exp Brain Res 1981;41:271-9.
5. Brown K, Kynoch P, Thompson R. Immunoreactive nervous system specific enolase (14-3-2 protein) in human serum and cerebrospinal fluid. Clin Chim Acta 1980;101:257-64.
6. Persson L, Hårdemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18:911-18.
7. Blomquist S, Johnsson P, Lührs K, et al. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. J Cardiothor Vasc Anesth 1997;11:699-703.
8. Gazzolo D, Vinesi P, Bartocci M, et al. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infant: correlation with cerebral doppler velocimetry. J Neurol Sci 1999;170:32-5.
9. Amer-Wåhlin I, Herbst A, Lindoff C, et al. Brain-specific NSE and S-100 proteins in umbilical blood after normal delivery. Clin Chim Acta 2001;304:57-63.
10. Gao F, Harris D, Sapsed-Byrne S. Neurone-specific enolase and Sangtec 100 assays during cardiac surgery. Part III. Does haemolysis affect their accuracy? Perfusion 1997;12:171-7.
11. Maschmann J, Erb MA, Heinemann MK, et al. Evaluation of protein S-100 concentrations in healthy newborns and seven newborns with perinatal ocidosis. Acta Paediatr 2000;89:553-5.
12. Zimmer DB, Cornwall EH, Landar A, et al. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-29.
13. Gazzolo D, Bruschettini M, Corvino V, et al. S100B protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. Clin Chem 2001;47:954-6.
14. Tiu S, Chan W, Heizmann C, et al. Differential expression of S100B and S100A6 in the human fetal and aged cerebral cortex. Dev Brain Res 2000;119:159-68.
15. Stefansson K, Wollmann RL, Moore BW, et al. S-100 protein in human chondrocytes. Nature 1982;295:63-4.